Navigation auf zora.uzh.ch

Search

ZORA (Zurich Open Repository and Archive)

Anxious depression as a clinically relevant subtype of pediatric major depressive disorder

Häberling, Isabelle; Baumgartner, Noemi; Emery, Sophie; Keller, Paola; Strumberger, Michael; Nalani, Kristin; Schmeck, Klaus; Erb, Suzanne; Bachmann, Silke; Wöckel, Lars; Müller-Knapp, Ulrich; Contin-Waldvogel, Brigitte; Rhiner, Bruno; Walitza, Susanne; Berger, Gregor (2019). Anxious depression as a clinically relevant subtype of pediatric major depressive disorder. Journal of Neural Transmission, 126(9):1217-1230.

Abstract

In adults, anxious depression has been identified as a more severe form of major depressive disorder (MDD), associated with higher depression severity, more suicidal ideation and worse treatment outcome. Research in pediatric depression, however, has been sparse. 126 children and adolescents aged 8-18 years with a primary diagnosis of MDD were categorized into a MDD-only group and an anxious depression group based on clinically elevated scores on the Beck Anxiety Inventory. One-third of the sample was classified as having anxious depression with females being overrepresented in the anxious depressed compared to the MDD-only group. 42.2% of the anxious depressed youth met diagnostic criteria for a comorbid anxiety disorder. Anxious depressed youth were more likely to suffer recurrent depressive episodes, showed higher depression severity and a unique pattern of depressive symptoms characterized by more severe sleep problems, more somatic complaints, more severely depressed mood and more frequent suicidal ideations. Scores on a suicidal ideation scale were increased even when controlling for overall depression severity. However, when comparing depressed patients with and without comorbid anxiety disorders, no differences in depression severity, symptom patterns or suicidal ideations were observed. The results indicate that high anxiety levels in depressed youth are clinically relevant, and given the increase in suicidal ideation, anxiety symptoms during depressive episodes should routinely be screened in clinical practice even in the absence of a fully formed comorbid anxiety disorder.

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Klinik für Konsiliarpsychiatrie und Psychosomatik
04 Faculty of Medicine > Psychiatric University Hospital Zurich > Department of Child and Adolescent Psychiatry
04 Faculty of Medicine > Neuroscience Center Zurich
04 Faculty of Medicine > Zurich Center for Integrative Human Physiology (ZIHP)
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Life Sciences > Neurology
Health Sciences > Neurology (clinical)
Health Sciences > Psychiatry and Mental Health
Life Sciences > Biological Psychiatry
Language:English
Date:1 September 2019
Deposited On:05 Sep 2019 15:00
Last Modified:01 Sep 2024 03:40
Publisher:Springer
ISSN:0300-9564
OA Status:Closed
Publisher DOI:https://doi.org/10.1007/s00702-019-02069-x
PubMed ID:31456039
Project Information:
  • Funder: SNSF
  • Grant ID: 33IC30_166826
  • Project Title: Omega-3 fatty acids as first-line treatment in Paediatric Depression. A 36-week, multi-centre, double-blind, placebo-controlled randomized superiority Study.

Metadata Export

Statistics

Citations

Dimensions.ai Metrics
5 citations in Web of Science®
7 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

2 downloads since deposited on 05 Sep 2019
0 downloads since 12 months
Detailed statistics

Authors, Affiliations, Collaborations

Similar Publications